Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(4):257; doi:10.1093/jnci/djk086
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Long-Term Preventive Effect of Tamoxifen on Breast Cancer Risk

Tamoxifen is not only an effective treatment for estrogen receptor (ER)-positive breast cancer, but it also reduces the risk of breast cancer in high-risk women. Reports from randomized trials show that both of these effects appear to persist beyond the active treatment period. However, tamoxifen also causes a range of side effects, including thromboembolic events and endometrial cancer. In this issue, Cuzick et al. (p. 272) report the results of an extended follow-up of the IBIS-I trial, which randomly assigned more than 7,000 high-risk women to take daily tamoxifen or . . . [Full Text of this Article]

Test of New Selection Protocol for Lynch Syndrome Screening

Risk of Secondary Sarcoma In Childhood Cancer Survivors

KISS1 Secretion and Processing and Metastasis Suppression

Bisphosphonate Dosing Regimens in a Metastasis Model


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Tamoxifen: An Enduring Star
Umberto Veronesi, Patrick Maisonneuve, and Andrea Decensi
J Natl Cancer Inst 2007 99: 258-260. [Extract] [Full Text] [PDF]

Toward a Consensus in Molecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome)
Henry T. Lynch, Jane F. Lynch, and Patrick M. Lynch
J Natl Cancer Inst 2007 99: 261-263. [Extract] [Full Text] [PDF]

Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer—96-Month Follow-up of the Randomized IBIS-I Trial
Jack Cuzick, John F. Forbes, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, and Anthony Howell
J Natl Cancer Inst 2007 99: 272-282. [Abstract] [Full Text] [PDF]

Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial
Trevor J. Powles, Sue Ashley, Alwynne Tidy, Ian E. Smith, and Mitch Dowsett
J Natl Cancer Inst 2007 99: 283-290. [Abstract] [Full Text] [PDF]

Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics
Kristina Lagerstedt Robinson, Tao Liu, Jana Vandrovcova, Britta Halvarsson, Mark Clendenning, Thierry Frebourg, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Päivi Peltomäki, Richard D. Kolodner, Mef Nilbert, and Annika Lindblom
J Natl Cancer Inst 2007 99: 291-299. [Abstract] [Full Text] [PDF]

Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study
Tara O. Henderson, John Whitton, Marilyn Stovall, Ann C. Mertens, Pauline Mitby, Debra Friedman, Louise C. Strong, Sue Hammond, Joseph P. Neglia, Anna T. Meadows, Leslie Robison, and Lisa Diller
J Natl Cancer Inst 2007 99: 300-308. [Abstract] [Full Text] [PDF]

Requirement of KISS1 Secretion for Multiple Organ Metastasis Suppression and Maintenance of Tumor Dormancy
Kevin T. Nash, Pushkar A. Phadke, Jean-Marc Navenot, Douglas R. Hurst, Mary Ann Accavitti-Loper, Elizabeth Sztul, Kedar S. Vaidya, Andra R. Frost, John C. Kappes, Stephen C. Peiper, and Danny R. Welch
J Natl Cancer Inst 2007 99: 309-321. [Abstract] [Full Text] [PDF]

Antitumor Effects of Clinical Dosing Regimens of Bisphosphonates in Experimental Breast Cancer Bone Metastasis
Florence Daubiné, Céline Le Gall, Juerg Gasser, Jonathan Green, and Philippe Clézardin
J Natl Cancer Inst 2007 99: 322-330. [Abstract] [Full Text] [PDF]